Barclays PLC — Major Shareholding Notification 2021

Feb 3, 2021

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)	ORD
Date of dealing	2 FEB 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,319,271	1.80%	605,631	0.47%
(2)	Derivatives (other than options):
		273,127	0.21%	441,267	0.34%
(3)	Options and agreements to
	purchase/sell:	6,000	0.00%	6,000	0.00%
	TOTAL:
		2,598,398	2.02%	1,052,898	0.82%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long			Short
	Number		(%)	Number		(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

3.DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	212.2400 USD
Purchase	2	211.6900 USD
Purchase	3	211.5833 USD
Purchase	6	210.8983 USD
Purchase	10	210.9900 USD
Purchase	13	211.9030 USD
Purchase	100	211.2000 USD
Purchase	147	211.5494 USD
Purchase	150	211.7500 USD
Purchase	500	211.9860 USD
Purchase	500	211.5990 USD
Purchase	522	211.6099 USD
Purchase	674	212.0747 USD
Purchase	689	211.3679 USD
Purchase	700	211.9143 USD
Purchase	700	211.6957 USD
Purchase	820	212.0017 USD
Purchase	900	211.9211 USD
Purchase	900	211.7400 USD
Purchase	900	212.1500 USD
Purchase	1,000	211.6365 USD
Purchase	1,200	211.6920 USD
Purchase	2,103	211.1220 USD
Purchase	3,054	211.8737 USD
Purchase	3,398	211.8970 USD
Purchase	4,814	210.9128 USD
Purchase	5,752	211.3327 USD
Purchase	6,259	211.1922 USD
Purchase	7,506	211.1201 USD
Purchase	9,318	211.1200 USD
Purchase	17,106	211.7329 USD
Sale	7	211.7085 USD
Sale	10	211.8115 USD
Sale	10	210.9900 USD
Sale	11	211.4363 USD
Sale	11	211.8563 USD
Sale	11	211.7895 USD
Sale	11	211.4218 USD
Sale	12	210.1591 USD
Sale	13	211.6019 USD
Sale	14	211.5789 USD
Sale	27	211.7719 USD
Sale	29	211.6600 USD
Sale	40	212.1850 USD
Sale	50	211.4900 USD
Sale	58	211.6800 USD
Sale	91	211.3700 USD
Sale	477	211.8256 USD
Sale	689	211.3679 USD
Sale	874	211.1469 USD
Sale	2,149	211.2775 USD
Sale	3,029	211.8669 USD
Sale	3,077	211.8994 USD
Sale	3,974	210.8690 USD
Sale	4,362	211.4787 USD
Sale	6,881	211.2240 USD
Sale	7,514	211.1201 USD
Sale	12,528	211.1200 USD
Sale	25,000	211.7668 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	3 FEB 2021
Contact name	Large Holdings Regulatory Operations
Telephone number	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210203005515/en/

BARCLAYS PLC